An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical practice, according to a study published in the journal Oncology Reports.
Molecular oncologist Fumihiro Higashino and colleagues deleted a gene involved in viral replication, called E4orf6, from a type of adenovirus. The team previously discovered that E4orf6 stabilizes a type of mRNA called ARE-mRNAs in the infected cells enabling viral replication. ARE-mRNAs are known to be stable in stressed cells and cancer cells, but rapidly degrade in normal cells.
In laboratory tests, they found that their modified adenovirus, called dl355, replicated and increased its number significantly more in cancer cells than it did in normal cells. Higashino explains “The E4orf6-lacking virus relies on the stable ARE-mRNAs in cancer cells for its replication.”
Some viruses can be used to treat cancers, as they replicate within the cells until they burst and die. The researchers infected several types of cultured cancer cells with 100 dl355 virus particles per cell and found that nearly all the cancer cells died within seven days. In contrast, most normal cells infected with the virus did not die, even after seven days. Several cancer cell lines managed to survive low doses of dl355, but all cancer cells were killed by the virus as the dose was increased. Tumour growth was also significantly suppressed when dl355 was administered to human tumour cells grown in mice.
Finally, the team compared the anticancer effects of dl355 with another anticancer adenovirus currently used in clinical practice, called dl1520. dl355 replication was higher in all cancer cell lines tested, including cervical and lung cancer cells, and was better at killing all but one type of cancer cell, compared to dl1520. Both viruses only killed very few normal cells.
The findings suggest that dl355 has potential to be an effective anticancer treatment, the team concludes. They suggest enhancing the stabilization of ARE-mRNAs in cancer cells could even further strengthen its effect, but Professor Higashino notes that further research is required. “While we think dl355 has the potential to be an effective treatment method in dealing with many types of cancers, much more research needs to be done. When we think of a timeline, at least five more years of further research may be required, possible more, on top of clinical trials,” Professor Higashino noted.
Learn more: Engineering a cancer-fighting virus
The Latest on: Engineered virus
via Google News
The Latest on: Engineered virus
- L.A. Coronavirus Report: Public Health Confirms 9 New Deaths, Five Day Average Increases To 4,097 New Cases; Dining Restrictions Modified – Updateon November 22, 2020 at 3:25 pm
On Sunday, the Los Angeles Department of Public Health reported that COVID-19 cases continue to remain at alarming levels as we continue to see an increase in hospitalizations. Public health has ...
- Legacy Virus: How the X-Men Beat Their Deadliest Threaton November 22, 2020 at 11:34 am
The Legacy Virus was a biological weapon meant to kill all mutants and the X-Men were no exception, suffering several casualties.
- Business owners upbeat about vaccine, wary as virus spreadson November 22, 2020 at 7:15 am
Promising news about a coronavirus vaccine has small business owners feeling more upbeat despite cases of the virus surging in many parts of the U.S. Owners hope consumers and ...
- Modified Mosquitoes Suppress Dengue in Field Trialon November 20, 2020 at 10:05 am
Distributing mosquitoes artificially infected with Wolbachia parasites in one Indonesian city slashed confirmed dengue virus illnesses in the targeted areas, researchers reported. Three years after a ...
- LA County Continues To See Virus Surge As Restrictions Ramp Upon November 20, 2020 at 6:57 am
Los Angeles County reported nearly 4,300 new cases Friday, down from Thursday’s daily record but still on pace to trigger more restrictions that would end in-person dining at restaurants, and possibly ...
- Adagio's COVID-19 antibody protects mice and zaps related viruses in lab testson November 20, 2020 at 5:05 am
A precursor of Adagio Therapeutics' lead drug candidate protected mice from COVID-19, and in lab tests, it neutralized two related coronaviruses known to be circulating in bats. The company aims to ...
- Decoy molecule draws deadly mosquito-borne virus away from the brainon November 19, 2020 at 5:18 pm
Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne virus that, in the worst case scenario, can infect the brain and become deadly. It’s notoriously difficult to treat, but now scientists ...
- Engineered immune cells elicit broad response to HIV in mice, offering hope for vaccineon November 19, 2020 at 4:47 pm
Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus has proven especially tricky to prevent with conventional antibodies, in part because it evolves so rapidly in the body. A ...
- Row Over Rule Of Law Infects EU Virus Summiton November 19, 2020 at 5:52 am
Hungary and Poland's opposition to Brussels' oversight over the rule of law will be top of the EU summit agenda on Thursday, overshadowing efforts to tackle the coronavirus epidemic. European Union ...
- Modified Starch Market : Segments Worth Observing Aiding Growth Factors | Cargill, Inc.on November 18, 2020 at 8:10 am
Corona Virus pandemic impact on the market which has affected every aspect of life globally. This has brought along several changes in market conditions and the Business areas. The rapidly changing ...
via Bing News